Vita, S.; Maffongelli, G.; Bartoli, T.A.; Benvenuto, D.; Marocco, R.; Rosati, S.; Mazzotta, V.; Del Borgo, C.; Mastrorosa, I.; De Marco, P.;
et al. Comparative Effectiveness of Antiviral Agents and Monoclonal Antibodies for Early SARS-CoV-2 Therapy in Immunocompromised Patients: A Multicenter Retrospective Cohort Study (March 2021–March 2022). Microorganisms 2025, 13, 1076.
https://doi.org/10.3390/microorganisms13051076
AMA Style
Vita S, Maffongelli G, Bartoli TA, Benvenuto D, Marocco R, Rosati S, Mazzotta V, Del Borgo C, Mastrorosa I, De Marco P,
et al. Comparative Effectiveness of Antiviral Agents and Monoclonal Antibodies for Early SARS-CoV-2 Therapy in Immunocompromised Patients: A Multicenter Retrospective Cohort Study (March 2021–March 2022). Microorganisms. 2025; 13(5):1076.
https://doi.org/10.3390/microorganisms13051076
Chicago/Turabian Style
Vita, Serena, Gaetano Maffongelli, Tommaso Ascoli Bartoli, Domenico Benvenuto, Raffaella Marocco, Silvia Rosati, Valentina Mazzotta, Cosmo Del Borgo, Ilaria Mastrorosa, Patrizia De Marco,
and et al. 2025. "Comparative Effectiveness of Antiviral Agents and Monoclonal Antibodies for Early SARS-CoV-2 Therapy in Immunocompromised Patients: A Multicenter Retrospective Cohort Study (March 2021–March 2022)" Microorganisms 13, no. 5: 1076.
https://doi.org/10.3390/microorganisms13051076
APA Style
Vita, S., Maffongelli, G., Bartoli, T. A., Benvenuto, D., Marocco, R., Rosati, S., Mazzotta, V., Del Borgo, C., Mastrorosa, I., De Marco, P., D’Abramo, A., Maggi, F., Antinori, A., Lichtner, M., Nicastri, E., & Group, C.
(2025). Comparative Effectiveness of Antiviral Agents and Monoclonal Antibodies for Early SARS-CoV-2 Therapy in Immunocompromised Patients: A Multicenter Retrospective Cohort Study (March 2021–March 2022). Microorganisms, 13(5), 1076.
https://doi.org/10.3390/microorganisms13051076
